Table 1.
Clinical and demographic patient characteristics.
Total | Normal* | AK | SCC | BCC | P value | |
---|---|---|---|---|---|---|
Gender** | ||||||
Male | 46 | 21 | 4 | 14 | 25 | 0.77*** |
Female | 4 | 4 | 0 | 2 | 2 | |
Race | ||||||
White | 49 | 24 | 4 | 15 | 27 | 0.57*** |
African American | 1 | 1 | 0 | 1 | 0 | |
Age | ||||||
<60 | 17 | 13 | 1 | 7 | 7 | 0.44*** |
60–70 | 14 | 7 | 1 | 3 | 9 | |
>70 | 19 | 5 | 2 | 6 | 11 | |
Skin site | ||||||
Nose | 14 | 6 | 2 | 2 | 8 | 0.71*** |
Cheeks | 14 | 7 | 0 | 8 | 6 | |
Ear | 9 | 5 | 1 | 1 | 5 | |
Scalp and forehead | 13 | 5 | 1 | 5 | 5 | |
Other | 7 | 4 | 0 | 2 | 3 |
*Normal skin samples were surgically obtained from uninvolved adjacent skin in patients undergoing resection for skin cancer.
**Some patients had more than one type of cancer and are counted in both groups.
***No significant difference in number of males and females, race, age, or skin site distribution per group by Fisher's exact test.